Presentation of a case of Wegener disease;Le cas clinique du mois: Présentation d'un cas de maladie de Wegener

Revue Medicale de Liege

Volumn 58, Issue 1, 2003, Pages 13-18

  Lakiss, N ^a   Duysinx, B ^b   Cornette, M ^c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c CHBA Seraing ^*  (Belgium)

Author keywords

ANCA; Pulmonary macronodules; Sinusitis; Vasculitis; Wegener

Indexed keywords

GRANULOCYTE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEIN ANTIBODY; PROTEIN PR3 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN DYSFUNCTION; CASE REPORT; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL FEATURE; ENT EXAMINATION; FEMALE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; LUNG BIOPSY; LUNG NODULE; LUNG STRUCTURE; MALAISE; SINUSITIS; SYMPTOMATOLOGY; SYSTEMIC DISEASE; VASCULITIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; LUNG; MIDDLE AGED; PEROXIDASE; RETINAL ARTERY OCCLUSION; VASCULITIS, CENTRAL NERVOUS SYSTEM; WEGENER GRANULOMATOSIS;

EID: 0037268796     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cordier JF.- Vascularites pulmonaires. Editions Techniques. Encycl. Méd. Chir. (Paris), Pneumologie, 6-024-D-10, 1994.
2. Fontenot A, Jennigs C, King T.- Pulmonary opacities and granulonephritis in a 15-year-old boy. Chest, 1998, 113, 525-27.
3. Kumar A, Mohan A et al.- Relapse of Wegener's granulomatosis in the first trimester of pregnancy: a case report. Br J Rheumatol, 1998, 37, 331-333.
4. ème éd. Flammarion, Paris, 2000, 741-762.
5. ème éd. 1998, 2204-2206.
6. Hoffman GS, Kerr GS, Leavitt RY, et al.- Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med, 1992, 116, 488.
7. Harman L, Margoc C.- Wegener's granulomatosis. Survey Ophthalmol, 1998, 42, 458-80.
8. Hoffman GS, Kerr GS, Leavitt RY, et al.- Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med, 1992, 116, 488-498.
9. Schnahel A, Holl-Uhich K, et al.- Efficacy of transbronchial biopsy in pulmonary vasculitides. Eur Respir J, 1997, 10, 2738-2743.
10. Kobold AC, Kallenberg CG, Cohen Tervaert JW.- Leucocyte membrane expression of proteinase PR 3 correlates with disease activity in patients with Wegener's granolomatosis. Br J Rheumatol, 1998, 37, 901-907.
11. Luisiri P, Lance J, Curran JJ.- Wegener's granulomatosis in pregnancy. 1997, 40, 1354-60.
12. Bradley JD, Brandt KD, Katz BP.- Infectious complications of cyclophosphamide treatment for vasculitis. Arthritis Rheum, 1989, 32, 45.
13. nd ed. WB Saunders, Philadelphia, 1979, 2196-2199.
14. Dune GF, Cotch MF, et al.- Wegener's granulomatosis: role of environmental exposures. Clin Exp Rheum, 1998, 16, 669-674.
15. Hoffman GS, Leavitt RY, Fleisher TA, et al.- Treatement of Wegener's granulomatosis with intermittent high doses of intravenous cyclophosphamide. Am J Med, 1990, 89, 103.
16. Chouaid C, Atassi C, Housset B.- Diagnostic des opacités rondes pulmonaires. Encycl Méd chir (Elsevir, Paris), Pneumologie, 6-090-A-20, 1997, 6p.
17. Reuter M, et al.- Pulmonary Wegener's granulomatosis: correlation between high-resolution CT findings and clinical scoring of disease activity. Chest, 1998, 114, 500-506.
18. Koldingsness W, Gran JT, Omdal R, et al.- Wegener's granulomatosis: long term follow-up of patients treated with pulse cyclophosphamide. Br J Rheumatol, 1998, 37, 659-664.
19. Goeken JA.- Antineutrophil cytoplasmic antibody-A useful serological marker of vasculitis. J Clin Immunol, 1991, 11, 161-174.
20. Cohen Tervaert JW, Gold Schmediny R, Henne RJ, et al.- Neutrophil cytoplasmic autoantibodies in Wegener's Granulomatosis. Lancet, 1989, I, 270.